Charles McDermott

Charles McDermott

Charles (Charlie) McDermott has more than 25 years of experience in the life sciences industry and has held roles of increasing responsibility in drug discovery, regulatory affairs, corporate development, commercial planning, and executive management. Most recently...
James Appleman, Ph.D.

James Appleman, Ph.D.

James (Jim) Appleman, Ph.D., is Chief Scientific Officer, Senior Vice President of R&D, and a cofounder of Primmune Therapeutics. He has more than 30 years of experience in building successful drug discovery organizations and has been an advisor to biotech,...
Curtis Scribner, M.D.

Curtis Scribner, M.D.

Curtis Scribner, M.D., is a board-certified internal medicine specialist with extensive experience in drug development as a clinical investigator, regulatory reviewer, and strategic product life cycle consultant. Dr. Scribner spent 10 years at the FDA’s Center for...
Richard Daniels

Richard Daniels

Richard Daniels is the Chief Operating Officer of Primmune and brings more than 25 years of experience in the pharmaceutical and biotech industry covering all stages of product development and commercialization in multiple therapeutic areas. Prior to joining Primmune...
Paulo Rangel

Paulo Rangel

Paulo Rangel is the Chief Business Officer and cofounder of Primmune and brings 25 years of experience in the pharmaceutical and related industries in both small and large companies. Before Primmune, Mr. Rangel was President, CEO, and cofounder of Evince Biosciences,...